Bovada Casino – Bovada Bonus Code For Online Casino and Betting Site In US 2025

New York City, NY, May 24, 2025 (GLOBE NEWSWIRE) — For U.S. players looking to combine online sports betting and casino games under one roof, Bovada Casino continues to be one of the most recognized names in the game. Whether you're into slots, blackjack, or looking for a secure place to place your NFL or […]

Bovada Casino – Bovada Bonus Code For Online Casino and Betting Site In US 2025

Bovada Casino – Bovada Bonus Code For Online Casino and Betting Site In US 2025 Bovada casino is the best online casino and betting site for real money and get bovada casino bonus code GlobeNewswire May 24, 2025 New York City, NY, May 24, 2025 (GLOBE NEWSWIRE) — For U.S. players looking to combine online

Best Online Therapy (2025): Talkiatry Recognized as Top Virtual Mental Health Platform by Expert Consumers

NEW YORK CITY, May 24, 2025 (GLOBE NEWSWIRE) — In recognition of changing mental health care dynamics and increased demand for accessible psychiatric services, Talkiatry has been named the top virtual mental health platform of 2025 by ExpertConsumers.org. This announcement highlights Talkiatry's role in redefining online mental health delivery through a medical-first approach, streamlined virtual

Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension and Cardiovascular Protection (ESH 2025)

(NASDAQ:MLYS), – Largest hypertension trial of an aldosterone synthase inhibitor to date demonstrated the efficacy of lorundrostat in over 1,000 participants with uncontrolled or resistant hypertension in a real-world setting – – Lorundrostat 50 mg dosed once daily demonstrated clinically meaningful and sustained reductions in systolic blood pressure, with a 16.9 mmHg reduction at Week

Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension and Cardiovascular Protection (ESH 2025)

Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension and Cardiovascular Protection (ESH 2025) GlobeNewswire May 24, 2025 – Largest hypertension trial of an aldosterone synthase inhibitor to date demonstrated the efficacy of lorundrostat in over 1,000 participants with

COMPUTEX 2025: MiTAC Powers Sustainable AI Data Centers with New Server & Cooling Tech

AtCOMPUTEX 2025, MiTAC Computing Technology Corp., a subsidiary of MiTAC Holdings Corp. (TWSE: 3706), unveiled its bold new vision: from hardware provider to full-solution AI and data center innovator. With future-ready solutions covering AI training and inference, high-performance computing (HPC), rack-level liquid cooling, GPU resource management, and real-time data mobility, MiTAC delivers an integrated platform

NET POWER SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NET Power Inc. – NPWR

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against NET Power Inc. (“Net Power” or the “Company”) (NYSE: NPWR), if they purchased the Company's securities

COMPASS DIVERSIFIED SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Compass Diversified Holdings – CODI

KahnSwick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 8, 2025 to file lead plaintiff applications in a securities class action lawsuit against Compass Diversified Holdings (NYSE: CODI), if they purchased the Company's securities between May 1, 2024 and May

Scroll to Top